Earnings FeedTerminal

⌘K

Home/Filings/8-K/0001181431-05-022544

8-K//Current report

GENAERA CORP 8-K

Accession 0001181431-05-022544

CIK 0000880431operating

View on SEC.gov Company Profile

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 9:38 AM ET

Size

27.5 KB

Accession

0001181431-05-022544

Documents

2 files

8-K
rrd76013.htmPrimary
EX-99.1
rrd76013_5163.htm
PRESS RELEASE OF THE COMPANY DATED APRIL 18, 2005 - "GENAERA RECEIVES REGULATORY AUTHORIZATION FOR A PIVOTAL PHASE II TRIAL IN CYSTIC FIBROSIS FOR LOMUCIN(TM)"

Issuer

GENAERA CORP

CIK 0000880431

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000880431

Filing Metadata

Form type: 8-K
Filed: Apr 18, 8:00 PM ET
Accepted: Apr 19, 9:38 AM ET
Size: 27.5 KB

View on SEC.gov